Publication | Open Access
Discovery and Structure−Activity Relationship of Quinuclidine Benzamides as Agonists of α7 Nicotinic Acetylcholine Receptors
214
Citations
10
References
2005
Year
PharmacotherapyChemical BiologyMolecular PharmacologyMedicinal ChemistryQuinuclidine BenzamidesChimeric ReceptorNeurochemistryBiochemistryNative Alpha7 NachrsReceptor (Biochemistry)Mechanism Of ActionNeuropharmacologyAlpha7 NachrPharmacologyFunctional SelectivityStructure−activity RelationshipNatural SciencesNeuropeptide ReceptorNeuroscienceMedicineDrug DiscoveryNeuropeptides
A library of benzamides was tested for alpha7 nicotinic acetylcholine receptor (nAChR) agonist activity using a chimeric receptor in a functional, cell-based, high-throughput assay. From this library, quinuclidine benzamides were found to have alpha7 nAChR agonist activity. The SAR diverged from the activity of this compound class verses the 5-HT(3) receptor, a structural homologue of the alpha7 nAChR. PNU-282987, the most potent compound from this series, was also shown to open native alpha7 nAChRs in cultured rat neurons and to reverse an amphetamine-induced gating deficit in rats.
| Year | Citations | |
|---|---|---|
1993 | 1.5K | |
1993 | 408 | |
1998 | 266 | |
1997 | 157 | |
(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor G. B. MULLEN, James Napier, Michael Balestra, Journal of Medicinal Chemistry PharmacotherapySocial SciencesMolecular PharmacologyMedicinal ChemistryNeurochemistry | 2000 | 132 |
2003 | 128 | |
1999 | 105 | |
1996 | 60 | |
1996 | 32 | |
1996 | 16 |
Page 1
Page 1